p53 overexpression is a prognosticator of poor outcome in esophageal cancer.
In conclusion, strong p53 immunostaining, but not TP53 deletion alone, is associated with unfavorable outcomes and may therefore represent a clinically useful molecular marker in esophageal cancer.
PMID: 30881503 [PubMed]
Source: Oncology Letters - Category: Cancer & Oncology Tags: Oncol Lett Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Esophagus Cancer | Fish | Skin Cancer | Squamous Cell Carcinoma | Study